Choi YJ, Sohn JW, Choi WS, Wie SH, Lee J, Lee JS,. Interim Estimates of 2023-2024 Seasonal Influenza Vaccine Effectiveness Among Adults in Korea. J Korean Med Sci. 2024 Apr 22;39(15):e146
In the 2023-2024 season, the influenza epidemic in South Korea peaked earlier than in recent years. In this study, we aimed to estimate the interim vaccine effectiveness (VE) of the influenza vaccination to prevent influenza during the early season. From November 1, 2023, to December 31, 2023, we enrolled 2,632 subjects with influenza-like illness from eight hospitals participating in hospital-based influenza morbidity and mortality surveillance. A retrospective test-negative case-control study was conducted to estimate the VE. The results showed an adjusted VE of 22.5% (95% confidence interval [CI], 6.6 to 35.8) for the total population. The adjusted VE was 22.3% (95% CI, 6.1 to 35.7) for influenza A and 9.4% (95% CI, -51.3 to 45.7) for influenza A/H1N1. Full results of the analysis will be reported.
See Also:
Latest articles in those days:
- Emergence of a human co-infected with seasonal influenza A (H3N2) virus and avian influenza A (H10N5) virus, China, December 2023 39 minute(s) ago
- Notes from the Field: Health Monitoring, Testing, and Case Identification Among Persons Exposed to Influenza A(H5N1) - Michigan, 2024 43 minute(s) ago
- Modeling transmission of avian influenza viruses at the human-animal-environment interface in Cuba 45 minute(s) ago
- Quantitative Risk Assessment of Wind-Supported Transmission of Highly Pathogenic Avian Influenza Virus to Dutch Poultry Farms via Fecal Particles from Infected Wild Birds in the Environment 46 minute(s) ago
- High pathogenicity avian influenza (HPAI) in Great Britain and Europe 52 minute(s) ago
[Go Top] [Close Window]